We are live on
!
Find out more
Celldex Therapeutics
CLDX
CLDX
130 hedge funds and large institutions have $645M invested in Celldex Therapeutics in 2020 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 33 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
308% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 13
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
43% more funds holding
Funds holding: 91 → 130 (+39)
38% more call options, than puts
Call options by funds: $11.8M | Put options by funds: $8.52M
38% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 24
35% more capital invested
Capital invested by funds: $477M → $645M (+$168M)
11.99% more ownership
Funds ownership: 81.05% → 93.04% (+12%)
Holders
130
Holders Change
+39
Holders Change %
+42.86%
% of All Funds
2.3%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
53
Increased
33
Reduced
24
Closed
13
Calls
$11.8M
Puts
$8.52M
Net Calls
+$3.25M
Net Calls Change
-$3.81M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$32.1M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$24.7M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$24M |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$18.5M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$13M |
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$45.5M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
-$17.8M |
| 3 |
Renaissance Technologies
New York
|
-$12.4M |
| 4 |
O
OrbiMed
New York
|
-$9.27M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$7.93M |
